Single Ascending Dose Study of ATH-097 in Healthy Participants

NCT07640269 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

This is a Phase I Study Conducted in Healthy Volunteers

Interventions

DRUG: ATH-097
DRUG: Placebo

Sponsor

Atheron Therapeutics, Ltd.